HPV as a marker for molecular characterization in head and neck oncology: Looking for a standardization of clinical use and of detection method(s) in clinical practice

Francesco Bussu, Camille Ragin, Paolo Boscolo-Rizzo, Davide Rizzo, Roberto Gallus, Giovanni Delogu, Patrizia Morbini, Massimo Tommasino

Research output: Contribution to journalReview article

Abstract

Background: A consensus about the most appropriate diagnostic method(s) for head and neck human papillomavirus (HPV)-induced carcinogenesis is still lacking because most of the commercially available assays have been designed for the cervix. Methods: This article summarizes current data and trends concerning HPV diagnostic strategies in oropharyngeal squamous cell carcinoma (OPSCC). Six main approaches are described. Results: The diagnostic gold standard for HPV-related OPSCC, focusing on E6/E7 mRNA detection, requires fresh samples. Because most frequently available samples are formalin-fixed paraffin-embedded (FFPE), the pros and cons of the different approaches were analyzed. Conclusions: In the FFPE samples, the immunohistochemistry of p16, which is considered appropriate to assess HPV-driven carcinogenesis in OPSCC according to the 8th American Joint Committee on Cancer TNM classification, may not be specific enough to become the diagnostic standard in the perspective of treatment deintensification. p16 may play a safer role in combination with another highly sensible assay. Other promising approaches are based on DNA detection through real-time polymerase chain reaction and RNAscope.

Original languageEnglish
JournalHead and Neck
DOIs
Publication statusPublished - Jan 1 2019

Fingerprint

Neck
Head
Squamous Cell Carcinoma
Paraffin
Formaldehyde
Carcinogenesis
Neoplasm Staging
Cervix Uteri
Real-Time Polymerase Chain Reaction
Immunohistochemistry
Messenger RNA
DNA
Neoplasms
Therapeutics

Keywords

  • FFPE
  • HPV
  • molecular characterization
  • oropharynx
  • treatment deintensification

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

HPV as a marker for molecular characterization in head and neck oncology : Looking for a standardization of clinical use and of detection method(s) in clinical practice. / Bussu, Francesco; Ragin, Camille; Boscolo-Rizzo, Paolo; Rizzo, Davide; Gallus, Roberto; Delogu, Giovanni; Morbini, Patrizia; Tommasino, Massimo.

In: Head and Neck, 01.01.2019.

Research output: Contribution to journalReview article

Bussu, Francesco ; Ragin, Camille ; Boscolo-Rizzo, Paolo ; Rizzo, Davide ; Gallus, Roberto ; Delogu, Giovanni ; Morbini, Patrizia ; Tommasino, Massimo. / HPV as a marker for molecular characterization in head and neck oncology : Looking for a standardization of clinical use and of detection method(s) in clinical practice. In: Head and Neck. 2019.
@article{44696b880d064b9bb74ce58fc94a78cd,
title = "HPV as a marker for molecular characterization in head and neck oncology: Looking for a standardization of clinical use and of detection method(s) in clinical practice",
abstract = "Background: A consensus about the most appropriate diagnostic method(s) for head and neck human papillomavirus (HPV)-induced carcinogenesis is still lacking because most of the commercially available assays have been designed for the cervix. Methods: This article summarizes current data and trends concerning HPV diagnostic strategies in oropharyngeal squamous cell carcinoma (OPSCC). Six main approaches are described. Results: The diagnostic gold standard for HPV-related OPSCC, focusing on E6/E7 mRNA detection, requires fresh samples. Because most frequently available samples are formalin-fixed paraffin-embedded (FFPE), the pros and cons of the different approaches were analyzed. Conclusions: In the FFPE samples, the immunohistochemistry of p16, which is considered appropriate to assess HPV-driven carcinogenesis in OPSCC according to the 8th American Joint Committee on Cancer TNM classification, may not be specific enough to become the diagnostic standard in the perspective of treatment deintensification. p16 may play a safer role in combination with another highly sensible assay. Other promising approaches are based on DNA detection through real-time polymerase chain reaction and RNAscope.",
keywords = "FFPE, HPV, molecular characterization, oropharynx, treatment deintensification",
author = "Francesco Bussu and Camille Ragin and Paolo Boscolo-Rizzo and Davide Rizzo and Roberto Gallus and Giovanni Delogu and Patrizia Morbini and Massimo Tommasino",
year = "2019",
month = "1",
day = "1",
doi = "10.1002/hed.25591",
language = "English",
journal = "Head and Neck Surgery",
issn = "1043-3074",
publisher = "Wiley-Liss Inc.",

}

TY - JOUR

T1 - HPV as a marker for molecular characterization in head and neck oncology

T2 - Looking for a standardization of clinical use and of detection method(s) in clinical practice

AU - Bussu, Francesco

AU - Ragin, Camille

AU - Boscolo-Rizzo, Paolo

AU - Rizzo, Davide

AU - Gallus, Roberto

AU - Delogu, Giovanni

AU - Morbini, Patrizia

AU - Tommasino, Massimo

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Background: A consensus about the most appropriate diagnostic method(s) for head and neck human papillomavirus (HPV)-induced carcinogenesis is still lacking because most of the commercially available assays have been designed for the cervix. Methods: This article summarizes current data and trends concerning HPV diagnostic strategies in oropharyngeal squamous cell carcinoma (OPSCC). Six main approaches are described. Results: The diagnostic gold standard for HPV-related OPSCC, focusing on E6/E7 mRNA detection, requires fresh samples. Because most frequently available samples are formalin-fixed paraffin-embedded (FFPE), the pros and cons of the different approaches were analyzed. Conclusions: In the FFPE samples, the immunohistochemistry of p16, which is considered appropriate to assess HPV-driven carcinogenesis in OPSCC according to the 8th American Joint Committee on Cancer TNM classification, may not be specific enough to become the diagnostic standard in the perspective of treatment deintensification. p16 may play a safer role in combination with another highly sensible assay. Other promising approaches are based on DNA detection through real-time polymerase chain reaction and RNAscope.

AB - Background: A consensus about the most appropriate diagnostic method(s) for head and neck human papillomavirus (HPV)-induced carcinogenesis is still lacking because most of the commercially available assays have been designed for the cervix. Methods: This article summarizes current data and trends concerning HPV diagnostic strategies in oropharyngeal squamous cell carcinoma (OPSCC). Six main approaches are described. Results: The diagnostic gold standard for HPV-related OPSCC, focusing on E6/E7 mRNA detection, requires fresh samples. Because most frequently available samples are formalin-fixed paraffin-embedded (FFPE), the pros and cons of the different approaches were analyzed. Conclusions: In the FFPE samples, the immunohistochemistry of p16, which is considered appropriate to assess HPV-driven carcinogenesis in OPSCC according to the 8th American Joint Committee on Cancer TNM classification, may not be specific enough to become the diagnostic standard in the perspective of treatment deintensification. p16 may play a safer role in combination with another highly sensible assay. Other promising approaches are based on DNA detection through real-time polymerase chain reaction and RNAscope.

KW - FFPE

KW - HPV

KW - molecular characterization

KW - oropharynx

KW - treatment deintensification

UR - http://www.scopus.com/inward/record.url?scp=85061453308&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061453308&partnerID=8YFLogxK

U2 - 10.1002/hed.25591

DO - 10.1002/hed.25591

M3 - Review article

AN - SCOPUS:85061453308

JO - Head and Neck Surgery

JF - Head and Neck Surgery

SN - 1043-3074

ER -